Alexander Mark Schobel is Chief Innovation/Tech Officer of Aquestive Therapeutics, Inc.. Currently has a direct ownership of 984,476 shares of AQST, which is worth approximately $4.65 Million. The most recent transaction as insider was on Mar 15, 2024, when has been sold 50,000 shares (Common Stock) at a price of $6.0 per share, resulting in proceeds of $300,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 984K
0% 3M change
0.16% 12M change
Total Value Held $4.65 Million

Alexander Mark Schobel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 15 2024
SELL
Open market or private sale
$300,000 $6.0 p/Share
50,000 Reduced 4.83%
984,476 Common Stock
Mar 09 2024
SELL
Payment of exercise price or tax liability
$28,767 $4.88 p/Share
5,895 Reduced 0.57%
1,034,476 Common Stock
Mar 08 2024
SELL
Open market or private sale
$129,750 $5.19 p/Share
25,000 Reduced 2.35%
1,040,371 Common Stock
Mar 07 2024
BUY
Grant, award, or other acquisition
-
82,500 Added 7.19%
1,065,371 Common Stock
Mar 09 2023
BUY
Grant, award, or other acquisition
-
100,000 Added 9.23%
982,871 Common Stock
Jun 08 2022
BUY
Open market or private purchase
$44,036 $0.96 p/Share
45,871 Added 4.94%
882,871 Common Stock
Feb 10 2021
SELL
Open market or private sale
$158,355 $6.75 p/Share
23,460 Reduced 2.73%
837,000 Common Stock
Feb 09 2021
SELL
Open market or private sale
$77,895 $6.75 p/Share
11,540 Reduced 1.32%
860,460 Common Stock
Feb 08 2021
SELL
Open market or private sale
$265,148 $6.5 p/Share
40,792 Reduced 4.47%
872,000 Common Stock
AMS

Alexander Mark Schobel

Chief Innovation/Tech Officer
Warren, NJ

Track Institutional and Insider Activities on AQST

Follow Aquestive Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AQST shares.

Notify only if

Insider Trading

Get notified when an Aquestive Therapeutics, Inc. insider buys or sells AQST shares.

Notify only if

News

Receive news related to Aquestive Therapeutics, Inc.

Track Activities on AQST